Big Buttons

• PCAC to discuss 503A bulks list substances

  FDA’s Pharmacy Compounding Advisory Committee has announced that it will hold two meetings (!) between now and year-end to consider recommending several bulk drug substances to the 503A Bulks List.  read more →

• Next APC regional meeting: Seattle

  The latest of APC’s new regional meetings — CompoundED UpDATE — is coming to the Seattle area October 3. read more →

• Don’t skip EduCon’s final (fantastic) session(s)

  The final session of this year’s EduCon is coming up in just a few weeks, and it’s a special double helping of legal goodness. read more →

• Welcome, new PFMs!

  We’ve added 31 Pharmacy-Facility Members since February! read more →

• Let’s talk about that Lilly announcement

  There’s been plenty of coverage of Eli Lilly’s announcement this week that it will sell vials of Zepbound directly to consumers at a discount. But the company seems to have left out a few important caveats. read more →

• Our response to the op-ed in The Hill

  The Hill published an editorial by Dr. Kenneth McCall titled “Fake, unsafe weight-loss drugs are a worsening public health dilemma” in which he makes unfounded claims about pharmacy compounding. Here’s the response from our CEO. read more →

• The shortage ends … then what? (Find out at CCH) 

  We’ve added a new session to the Compounders on Capitol Hill lineup. Don’t miss the discussion of what’s on many a compounder’s (and regulators’ … and reporters’...) mind. read more →

• A new bronze corporate patron

  A big welcome to Ro, APC’s newest tier-level corporate patron! read more →

More News

Introducing “Reading & Leveraging a Certificate of Analysis”: A three-part learning series from the Alliance for Pharmacy Compounding.

Ask any competent compounder and they’ll tell you: The certificate of analysis matters — and your ability to correctly read one, and leverage it in producing compounded medications, is key to delivering a product that is not just safe, but precisely prepared for your patients’ specific needs.

Get it wrong, and you don’t just waste ingredients — you may be putting your patients at risk. This three-part series from APC is designed for compounding pharmacy teams, to polish their skillset, grow their expertise, and keep them compliant with the Compounder’s Code of Ethics.

It’s such an important topic that we’re providing a special $99 rate for pharmacists, $69 for technicians — that includes all three sessions.

Leveraging a COA: Raw Material Revealed

June 22; 2:00–3:00pm EDT
Presenter: Dr. Tom Kupiec, ARL Bio Pharma; Oklahoma City, OK

• Understanding all those fields
• How COAs differ lot to lot
• Manufacturer COAs versus repackaged/vendor COAs
• Repackaged testing on raw material
• Where to find a missing COA
• How to read an API label
• Case studies and cautionary tales

Leveraging a COA: The Arithmetic

July 13; 2:00–3:00pm EDT
Presenter: Anthony Campbell, PharmD, BCSCP, Wells Pharmacy Network; Ocala, Florida

• Determining the correct chemical
• Calculations based on COA data
• Assay vs. potency
• Loss on drying/residual solvents/-hydrates
• Salt ester conversions
• How to document production records
• Lot-to-lot differences in COA
• Excipient changes necessary

Leveraging a COA: Risk Mitigation

August 10; 2:00–3:00pm EDT
Presenter: Anthony Grzib, RPh, Wedgewood Pharmacy; Swedesboro, NJ

• Procedures and training for performing COA review
• Controlling material storage conditions
• How to ensure lot-to-lot consistency of material
• Due diligence and verification of COA data

All three courses are only $99 for pharmacists and $69 for technicians!